Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: A systematic review and meta-analysis
Objectives To identify factors influencing the diagnostic performance of the quantitative
imaging biomarkers ADC and ADCratio in prostate cancer (PCa) detection. Materials and …
imaging biomarkers ADC and ADCratio in prostate cancer (PCa) detection. Materials and …
A pilot study of multidimensional diffusion MRI for assessment of tissue heterogeneity in prostate cancer
BJ Langbein, F Szczepankiewicz, CF Westin… - Investigative …, 2021 - journals.lww.com
Objectives The objectives of this exploratory study were to investigate the feasibility of
multidimensional diffusion magnetic resonance imaging (MddMRI) in assessing diffusion …
multidimensional diffusion magnetic resonance imaging (MddMRI) in assessing diffusion …
Machine learning and multiparametric MRI for early diagnosis of prostate cancer
D Bonekamp, HP Schlemmer - Der Urologe, 2021 - Springer
In the last few years, the early diagnosis of prostate cancer has continued to shift from
systematic biopsies to multiparametric MRI (mpMRI)-guided/MRI-transrectal ultrasound …
systematic biopsies to multiparametric MRI (mpMRI)-guided/MRI-transrectal ultrasound …
Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions
KS Zhang, CJO Neelsen, M Wennmann… - European Journal of …, 2023 - Elsevier
Purpose This study aimed to assess repeatability after repositioning (inter-scan), intra-rater,
inter-rater and inter-sequence variability of mean apparent diffusion coefficient (ADC) …
inter-rater and inter-sequence variability of mean apparent diffusion coefficient (ADC) …
Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement
YS Lee, MH Choi, YJ Lee, D Han… - The British Journal of …, 2022 - academic.oup.com
Objectives: To assess the apparent diffusion coefficient (ADC) values and the T1 and T2
values derived from nonenhanced (NE) and contrast-enhanced (CE) magnetic resonance …
values derived from nonenhanced (NE) and contrast-enhanced (CE) magnetic resonance …
[HTML][HTML] Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naïve patients with PSA 4~ 20 ng/ml
L Ren, Y Chen, Z Liu, G Huang, W Wang… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Methods This retrospective and single-center study included 389 biopsy-naïve patients with
PSA level 4~ 20 ng/ml, of whom 197 underwent prebiopsy mpMRI of the prostate. The …
PSA level 4~ 20 ng/ml, of whom 197 underwent prebiopsy mpMRI of the prostate. The …
Non-timely clinically applicable ADC ratio in prostate mpMRI: a comparison with fusion biopsy results
Z Falaschi, S Tricca, S Attanasio, M Billia, C Airoldi… - Abdominal …, 2022 - Springer
Purpose The purpose of the study was to assess the diagnostic accuracy of ADC ratio and to
evaluate its efficacy in reducing the number of false positives in prostatic mpMRI. Materials …
evaluate its efficacy in reducing the number of false positives in prostatic mpMRI. Materials …
Künstliche Intelligenz (KI) in der Radiologie?
D Bonekamp, HP Schlemmer - Der Urologe, 2022 - Springer
Wir befinden uns mitten in einer digitalen Revolution der Medizin. Da stellt sich die Frage,
ob besonders Fächer wie die Radiologie, die sich oberflächlich betrachtet mit der …
ob besonders Fächer wie die Radiologie, die sich oberflächlich betrachtet mit der …
Application of an inline synthetic high b-value reduced filed-of-view diffusion weighted imaging on differentiation prostate cancer from benign prostatic hyperplasia
Q Zhou, Q Tang, L Sang, C Liu, L Xu, W Liu, W Chen - 2023 - researchsquare.com
Background: This study aimed to evaluate the feasibility of reduced full-of-view synthetic
high-b-value diffusion weighted images (rFOV-syDWIs) in the clinical application of prostate …
high-b-value diffusion weighted images (rFOV-syDWIs) in the clinical application of prostate …